Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings

dc.contributor.author	Asensio-López, María-del-Carmen
dc.contributor.author	Severino, Paolo
dc.contributor.author	Lax, Antonio
dc.date.accessioned	2026-03-09T08:30:17Z
dc.date.available	2026-03-09T08:30:17Z
dc.date.issued	2025-04-28
dc.identifier.citation	Asensio-Lopez MDC, Severino P, Lax A. Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings. Front Pharmacol. 28 de abril de 2025;16:1607362. doi:10.3389/fphar.2025.1607362
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/24969
dc.language.iso	eng
dc.publisher	FRONTIERS MEDIA SA
dc.rights	Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri	https://creativecommons.org/licenses/by/4.0/deed.es
dc.title	Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings
dc.type	info:eu-repo/semantics/article
dc.identifier.pmid	40356986
dc.relation.publisherversion	https://www.frontiersin.org/articles/10.3389/fphar.2025.1607362/full
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.identifier.doi	10.3389/fphar.2025.1607362
dc.journal.title	Frontiers in Pharmacology
dc.identifier.essn	1663-9812